16/2024 Information on Medicalgorithmics S.A.’s Agreement to Establish a LoanLine with BioFund Capital Management LLC
Current Report No: 16/2024 Date: 26.06.2024 r. Legal Basis: Article 17, Section 1 of the MAR Regulation – Confidential Information The Management Board of Medicalgorithmics S.A., based in Warsaw “Company”, announces the signing of an agreement on June 25, 2024, to establish a loan line “Agreement” with the Company’s shareholder, BioFund Capital Management LLC “BioFund”. The […]
15/2024 Information on Medicalgorithmics S.A.’s FDAApproval for Use of the DeepRhythm Platform in the US Market
Current Report No: 15/2024 Date: 24.06.2024 r. Legal Basis: Article 17, Section 1 of the MAR Regulation – Confidential Information The Management Board of Medicalgorithmics S.A., based in Warsaw, Poland “Company” informs that the US Food and Drug Administration FDA has granted approval for the Company’s new diagnostic platform: DeepRhythm Platform DRP to be used in […]
14/2024 List of shareholders holding at least 5 % of the total number of votes at the Ordinary General Meeting of Medicalgorithmics S.A. on June 12, 2024
Raport bieżący nr: 14/2024 Data sporządzenia: 12.06.2024 Podstawa prawna: Article 70(3) of the Act on Public Offering — General Meeting list above 5 % The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (“Company”), hereby informs that the shareholders present at the Ordinary General Meeting of the Company convened for June 12, […]
13/2024 Resolutions of the Ordinary General Meeting of Medicalgorithmics S.A. held on June 12, 2024
Current Report No: 13/2024 Date: 12.06.2024 r. Legal Basis: Art. 56 sec. 1 point 2 of the Act on Public Offering – current and periodic information The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company”) informs that on June 12, 2024, Mr. Andrzej Gładysz resigned from his membership in the […]
12/2024 Submission of candidacy to the Supervisory Board of the Company
Raport bieżący nr: 12/2024 Data sporządzenia: June 12, 2024 Podstawa prawna: Article 56(1)(2) of the Act on Public Offering – Current and Periodic Information The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company”) informs that on June 12, 2024, the Company received from Powszechne Towarzystwo Emerytalne PZU S.A. – representing […]
11/2024 Resignation of a member of the Company’s Supervisory Board
Current Report No: 11/2024 Date: June 12, 2024 Legal Basis: Art. 56 (1) (2) of the Public Offering Act – current and periodic information The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company”) informs that on June 12, 2024, Mr. Andrzej Gładysz resigned from his membership in the Supervisory Board […]
10/2024 Notification of transactions performed by a person discharging managerial responsibilities received in accordance with Article 19 of the MAR Regulation
Current Report No: 10/2024 Date: June 10, 2024 Legal Basis: Article 19 (3) of the MAR Regulation – information on transactions performed by person discharging managerial responsibilities The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company“) informs, pursuant to Article 19 (3) of the Regulation (EU) No. 596/2014 of the […]
9/2024 Submission of the Candidacy of Przemysław A. Schmidt for Member of the Supervisory Board of the Company and Draft Resolution on Matters Included in the Agenda of the Ordinary General Meeting of Medicalgorithmics S.A. Convened for June 12, 2024
Current Report No: 9/2024 Date: May 22, 2024 Legal Basis: Article 56 (1) (2) of the Offering Act – current and periodic information The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company“) hereby informs that on May 21, 2024 the Company held from the Company’s shareholder – Biofund Capital Management […]
8/2024 Medicalgorithmics Has Recovered Nearly 50% of US Sales Compared to Q4 2023
Current Report No: 8/2024 Date: May 20, 2024 Legal Basis: Article 17(1) of the MAR Regulation – Confidential Information The Management Board of Medicalgorithmics S.A., based in Warsaw (the “Company”; the “Issuer”), informs that the Company has estimated the value of recurring, average monthly revenues solely from ECG data analysis services from the portfolio of […]
7/2024 Documents to be discussed at the Ordinary General Meeting of Medicalgorithmics S.A. convened for June 12, 2024
Current report no.: 7/2024 Date: May 16, 2024 Legal basis: Article 56 (1) (2) of the Offering Act – current and periodic information With reference to the content of current report No. 6/2024 dated May 15, 2024, the Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company“), encloses the Report of […]
6/2024 Information on convening the Ordinary General Meeting of Medicalgorithmics S.A. together with the content of draft resolutions
Current report no.: 6/2024 Date: 22.11.2023 Legal basis: Article 56 (1) (2) of the Offering Act – current and periodic information Management Board of Medicalgorithmics S.A. with its seat in Warsaw (“the Company”), hereby informs about the convening of the Ordinary General Meeting of the Company on June 12, 2024, at 2:00 p.m. at the […]
5/2024 Recommendation of the Management Board on the appropriation of profit for fiscal year 2023
Current Report No 5/2024 Date of preparation: May 14, 2024 Legal basis: Art. 17 para. 1 of MAR Regulation – confidential information The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company“) informs that it has adopted a resolution recommending to the Ordinary General Meeting of the Company to allocate the […]